The recent advent of "-omics" technologies have heralded a new era of personalized medicine. Personalized medicine is referred to as the ability to segment heterogeneous subsets of patients whose response to a therapeutic intervention within each subset is homogeneous. This new paradigm in healthcare is beginning to affect both research and clinical practice. The key to success in personalized medicine is to uncover molecular biomarkers that drive individual variability in clinical outcomes or drug responses. In this review, we begin with an overview of personalized medicine in breast cancer and illustrate the most encountered statistical approaches in the recent literature tailored for uncovering gene signatures.
Biomarkers ; Breast ; Breast Neoplasms ; Delivery of Health Care ; Humans ; Precision Medicine

Purpose: This study examined the effects of action observational training to improve the gait function for patients with stroke. Methods: The participants were divided into two groups: right hemiplegia group (n=12) and left hemiplegia group (n=12). All groups received conventional therapy for five sessions for 30 minutes, each for three weeks. Left and right hemiplegia group practiced additional action observational training for five sessions for 20 minutes each for three weeks. They participated in three weeks of action observational training coupled with immediate physical practice (intervention), followed by a final assessment. The duration of each action observation video sequence was 10 minutes, followed immediately by practice of the observed motor skill (10 minutes). The gait velocity, cadence, swing time, step length, and BOS (base of support) were examined using the GAITRite system. Results: The results of this study showed significant improvement in the gait function. The outcomes of the gait abilities from gait velocity, cadence, swing time, step length of the affected side, and BOS (base of support) were improved significantly in the right hemiplegia group (p<0.05). In the left hemiplegia group, there was no significant improvement in the gait velocity, cadence, and BOS except for the swing time and step length of the affected side. The left and right group comparisons between the groups were not significant (p<0.05). Conclusion Action observation training improves the gait function. These results suggest that action observational training is feasible and suitable for stroke patients.

Purpose: This study examined the effects of action observational training to improve the gait function for patients with stroke. Methods: The participants were divided into two groups: right hemiplegia group (n=12) and left hemiplegia group (n=12). All groups received conventional therapy for five sessions for 30 minutes, each for three weeks. Left and right hemiplegia group practiced additional action observational training for five sessions for 20 minutes each for three weeks. They participated in three weeks of action observational training coupled with immediate physical practice (intervention), followed by a final assessment. The duration of each action observation video sequence was 10 minutes, followed immediately by practice of the observed motor skill (10 minutes). The gait velocity, cadence, swing time, step length, and BOS (base of support) were examined using the GAITRite system. Results: The results of this study showed significant improvement in the gait function. The outcomes of the gait abilities from gait velocity, cadence, swing time, step length of the affected side, and BOS (base of support) were improved significantly in the right hemiplegia group (p<0.05). In the left hemiplegia group, there was no significant improvement in the gait velocity, cadence, and BOS except for the swing time and step length of the affected side. The left and right group comparisons between the groups were not significant (p<0.05). Conclusion Action observation training improves the gait function. These results suggest that action observational training is feasible and suitable for stroke patients.

BACKGROUND AND OBJECTIVES: Staphylococcus aureus (S. aureus) exotoxins have been implicated in the pathogenesis of chronic sinusitis with nasal polyp. The aim of this study was to identify the interplay of S. aureus exotoxins between the nasal mucus and nasal polyp tissue. SUBJECTS AND METHOD: We have selected 30 nasal polyp with chronic sinusitis patients and 10 controls withrhinoplasty without sinusitis. Nasal mucus culture was done by smearing in nasal polyp and middle meatus. PCR analysis of the nasal lavage and immunohistochemical stainingin nasal tissue were done for the presence of S. aureus exotoxins (SEA and TSST-1). RESULTS: Nasal culture results were positive for S. aureus in 27% of the nasal polyp group compared to 10% ofthe control group. PCR analysis for SEA and TSST-1 in the nasal lavage demonstrated remarkable expression in the nasal polyp group (SEA:53%, TSST-1:60%) compared to the control group (SEA:20%, TSST-1:10%). In addition, immunohistochemical staining of nasal tissues reflected significantly higher expression of S. aureus exotoxin in the nasal polyp group (SEA:20%, TSST-1:33%) compared to the control group (SEA:0%, TSST-1:0%). There was a significant correlation between the exotoxins of nasal lavage and nasal polyp. CONCLUSION: Our results demonstrated that the S. aureus exotoxin in the nasal cavity might invade the nasal mucosa and have some role to play in the pathogenesis of nasal polyp.
Bacterial Toxins ; Enterotoxins ; Exotoxins ; Humans ; Mucus ; Nasal Cavity ; Nasal Lavage ; Nasal Mucosa ; Nasal Polyps ; Polymerase Chain Reaction ; Sinusitis ; Staphylococcus ; Staphylococcus aureus ; Superantigens

Background: There is little information about the airborne hazardous agents released during the heat treatment when manufacturing a welding material. This study aimed to evaluate the airborne hazardous agents generated at welding material manufacturing sites through area sampling. Methods: concentration of airborne particles was measured using a scanning mobility particle sizer and optical particle sizer. Total suspended particles (TSP) and respirable dust samples were collected on polyvinyl chloride filters and weighed to measure the mass concentrations. Volatile organic compounds and heavy metals were analyzed using a gas chromatography mass spectrometer and inductively coupled plasma mass spectrometer, respectively. Results: The average mass concentration of TSP was 683.1 ± 677.4 μg/m3, with respirable dust accounting for 38.6% of the TSP. The average concentration of the airborne particles less than 10 μm in diameter was 11.2–22.8 × 104 particles/cm3, and the average number of the particles with a diameter of 10–100 nm was approximately 78–86% of the total measured particles (<10 μm). In the case of volatile organic compounds, the heat treatment process concentration was significantly higher (p < 0.05) during combustion than during cooling. The airborne heavy metal concentrations differed depending on the materials used for heat treatment. The content of heavy metals in the airborne particles was approximately 32.6%. Conclusions Nanoparticle exposure increased as the number of particles in the air around the heat treatment process increases, and the ratio of heavy metals in dust generated after the heat treatment process is high, which may adversely affect workers' health.

Background: CycloZ, a combination of cyclo-His-Pro and zinc, has anti-diabetic activity. However, its exact mode of action remains to be elucidated. Methods: KK-Ay mice, a type 2 diabetes mellitus (T2DM) model, were administered CycloZ either as a preventive intervention, or as a therapy. Glycemic control was evaluated using the oral glucose tolerance test (OGTT), and glycosylated hemoglobin (HbA1c) levels. Liver and visceral adipose tissues (VATs) were used for histological evaluation, gene expression analysis, and protein expression analysis. Results: CycloZ administration improved glycemic control in KK-Ay mice in both prophylactic and therapeutic studies. Lysine acetylation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha, liver kinase B1, and nuclear factor-κB p65 was decreased in the liver and VATs in CycloZ-treated mice. In addition, CycloZ treatment improved mitochondrial function, lipid oxidation, and inflammation in the liver and VATs of mice. CycloZ treatment also increased the level of β-nicotinamide adenine dinucleotide (NAD+), which affected the activity of deacetylases, such as sirtuin 1 (Sirt1). Conclusion Our findings suggest that the beneficial effects of CycloZ on diabetes and obesity occur through increased NAD+ synthesis, which modulates Sirt1 deacetylase activity in the liver and VATs. Given that the mode of action of an NAD+ booster or Sirt1 deacetylase activator is different from that of traditional T2DM drugs, CycloZ would be considered a novel therapeutic option for the treatment of T2DM.